VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 4323 · 119th Congress

Ensuring Access to Lower-Cost Medicines for Seniors Act

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Not yet voted on. This bill is still a proposal: it hasn't reached a floor vote, and its text can change in committee or on the floor before any vote.

2 cosponsors · 2 D

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill requires prescription drug plans under the Medicare prescription drug benefit to include generic drugs and biosimilars on their formularies.

What it does: CRS summary · Introduced in Senate · Apr 16, 2026

Ensuring Access to Lower-Cost Medicines for Seniors Act

This bill requires prescription drug plans under the Medicare prescription drug benefit to include generic drugs and biosimilars on their formularies.

Specifically, the bill requires plans that use formularies to include generic drugs and biosimilars on the formularies and without any requirements (e.g., prior authorization requirements) that are more restrictive as compared to those for brand-name drugs and biologics. Plans that use cost-sharing tiers must also have specific tiers for generic drugs and biosimilars, in accordance with certain limitations.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Ensuring Access to Lower-Cost Medicines for Seniors Act

Latest action (Apr 16, 2026): Read twice and referred to the Committee on Finance.

Policy area: Health · Origin: Senate · Introduced: Apr 16, 2026

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.